<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; Video</title>
	<atom:link href="http://www.newtbdrugs.org/blog/tag/video/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Mon, 21 May 2012 20:34:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Kick TB Campaign:  Scoring Big in South Africa and Beyond</title>
		<link>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/</link>
		<comments>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 19:22:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3403</guid>
		<description><![CDATA[The Kick TB Campaign is a unique project that uses the World's most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with TB Alert&#8217;s Mike Mandelbaum</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/#comments</comments>
		<pubDate>Thu, 21 Jul 2011 16:03:09 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2977</guid>
		<description><![CDATA[Mike Mandelbaum is Chief Executive of TB Alert, which is the UK's National and International Tuberculosis charity - the only British charity working solely on fighting TB in the UK and overseas.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Jenniffer Dietrich, Challenge Facility for Civil Society</title>
		<link>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/</link>
		<comments>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/#comments</comments>
		<pubDate>Fri, 01 Jul 2011 13:22:20 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2912</guid>
		<description><![CDATA[Jenniffer Dietrich is Technical Officer at the Challenge Facility for Civil Society of the Stop TB Partnership. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Global Fund in the Dominican Republic</title>
		<link>http://www.newtbdrugs.org/blog/video-global-fund-in-the-dominican-republic/</link>
		<comments>http://www.newtbdrugs.org/blog/video-global-fund-in-the-dominican-republic/#comments</comments>
		<pubDate>Thu, 23 Jun 2011 12:00:23 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[dominican republic]]></category>
		<category><![CDATA[global fund]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2858</guid>
		<description><![CDATA[This video documents what the Global Fund has done and can do more of to save lives and prevent infections by engaging affected communities.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-global-fund-in-the-dominican-republic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Global Fund Impact in Indonesia</title>
		<link>http://www.newtbdrugs.org/blog/video-global-fund-impact-in-indonesia/</link>
		<comments>http://www.newtbdrugs.org/blog/video-global-fund-impact-in-indonesia/#comments</comments>
		<pubDate>Sat, 18 Jun 2011 19:13:27 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[global fund]]></category>
		<category><![CDATA[indonesia]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2836</guid>
		<description><![CDATA[This video presents interviews with a diverse range of stakeholders on the positive impact that Global Fund financing has had for Indonesia's national programme. This post also includes another perspective from Kenya.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-global-fund-impact-in-indonesia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Announcement:  World-Renowned Pulmonologist Michael Iseman Joins Oxford Immunotec</title>
		<link>http://www.newtbdrugs.org/blog/announcement-world-renowned-pulmonologist-michael-iseman-joins-oxford-immunotec/</link>
		<comments>http://www.newtbdrugs.org/blog/announcement-world-renowned-pulmonologist-michael-iseman-joins-oxford-immunotec/#comments</comments>
		<pubDate>Thu, 02 Jun 2011 14:46:50 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Diagnostics]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2711</guid>
		<description><![CDATA[Dr. Michael D. Iseman, a world renowned pulmonologist and leading expert on tuberculosis has joined Oxford Immunotec as the Senior Scientific Advisor. In May 2010, the WGND had the honor of interviewing Dr. Iseman in our "Voices from the Fight to Stop TB" series. We congratulate Dr. Iseman on is new position!]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/announcement-world-renowned-pulmonologist-michael-iseman-joins-oxford-immunotec/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with Dr. Mark Cotton &#8211; Part Two</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-two/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-two/#comments</comments>
		<pubDate>Thu, 12 May 2011 11:00:46 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2566</guid>
		<description><![CDATA[Dr. Mark Cotton is Director of Children's Infectious Diseases Clinical  Research Unit (KID-CRU) at University of Stellenbosch in Cape Town,  South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been focusing on it for more than 20 years.  This is part two of our interview with him.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-two/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Private TB Drug Market is Larger than Expected</title>
		<link>http://www.newtbdrugs.org/blog/private-tb-drug-market-is-larger-than-expected/</link>
		<comments>http://www.newtbdrugs.org/blog/private-tb-drug-market-is-larger-than-expected/#comments</comments>
		<pubDate>Wed, 04 May 2011 21:30:49 +0000</pubDate>
		<dc:creator>TB Alliance</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[market access]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[india]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2603</guid>
		<description><![CDATA[The first detailed study of the private tuberculosis (TB) drug market, published on May 4th, in the PLoS ONE journal, finds that the market is surprisingly large, and has irregular practices that could be driving treatment failures and contributing to the emergence of multidrug-resistant TB (MDR-TB).]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/private-tb-drug-market-is-larger-than-expected/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with Dr. Mark Cotton &#8211; Part One</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-one/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-one/#comments</comments>
		<pubDate>Thu, 28 Apr 2011 11:00:03 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2559</guid>
		<description><![CDATA[Dr. Mark Cotton is Director of Children's Infectious Diseases Clinical Research Unit (KID-CRU) at University of Stellenbosch in Cape Town, South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been focusing on it for more than 20 years. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-one/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CNN News Coverage and FIND Presentation on Rapid TB test, Xpert MTB/RIF</title>
		<link>http://www.newtbdrugs.org/blog/cnn-news-coverage-and-find-presentation-on-rapid-tb-test-xpert-mtbrif/</link>
		<comments>http://www.newtbdrugs.org/blog/cnn-news-coverage-and-find-presentation-on-rapid-tb-test-xpert-mtbrif/#comments</comments>
		<pubDate>Thu, 14 Apr 2011 21:21:08 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Diagnostics]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2470</guid>
		<description><![CDATA[CNN featured TB diagnostic Xpert MTB/RIF in its Inside Africa program and looked at the implementation of Xpert MTB/RIF in Uganda.  In addition, the CORE Group hosted an online presentation on Xpert MTB/RIF from Elizabeth Talbot, Associate Professor of Infectious Diseases and International Health at Dartmouth Hitchcock Medical Center, and Medical Scientist, FIND: Foundation for Innovative New Diagnostics.  Results of a survey of their TB Working Group listserv also is included.
 
]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/cnn-news-coverage-and-find-presentation-on-rapid-tb-test-xpert-mtbrif/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

